发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER |
摘要 |
The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. Mycobacterium w is administered to mammals suffering from desmocollin-3 expressing cancers. The administration of Mycobacterium w results in control of tumor and improvement in survival. Mycobacterium w can also be used along with other therapeutic agent(s)/modalities as per the requirement. The squamous type of non small cell lung cancer is known to be desmocollin-3 expressing cancer. Other cancers also express desmocollin-3. |
申请公布号 |
EP2663318(B1) |
申请公布日期 |
2015.03.18 |
申请号 |
EP20120702318 |
申请日期 |
2012.01.10 |
申请人 |
CADILA PHARMACEUTICALS LTD. |
发明人 |
KHAMAR, BAKULESH MAFATLAL;MODI, INDRAVADAN AMBALAL |
分类号 |
C12N1/20;A61K35/74;A61K39/00;A61K39/04;A61P35/00 |
主分类号 |
C12N1/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|